Skip to content
Catalyst

chondroitin sulfateFinding

Chondroitin sulfate decreases serious adverse event incidence

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).”
Quoted verbatim from Chondroitin for osteoarthritis.
This finding among the 11 findings on its endpoint

chondroitin sulfate

Serious adverse event incidence

lowers

Effect as reported

0.4odds ratio

CI 0.19 to 0.82

Who
adults with osteoarthritis (knee, hip or hand); pooled across 6 trials
Dose studied
not reported

Very limited evidencePMID 25629804 · 2015

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PAA23GV8R418ZH4NMYN76M